The Walter and Eliza Hall Institute of Medical Research is Australia's oldest medical research institute. In 2011, the institute is home to more than 650 researchers who are working to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C. Located in Parkville, Melbourne, it is closely associated with The University of Melbourne and The Royal Melbourne Hospital. The institute also has a campus at La Trobe University. The institute was founded in 1915 using funds from a trust established by Eliza Hall following the death of her husband Walter Russell Hall. The institute owes its origin to the inspiration of Harry Brookes Allen, who encouraged the use of a small portion of the charitable trust to found a medical research institute. The vision was for an institute that 'will be the birthplace of discoveries rendering signal service to mankind in the prevention and removal of disease and the mitigation of suffering.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies.
Aug 2, 2018
3
2467
As we age our thymus shrinks and is replaced by fatty tissue, losing its essential ability to grow and develop T cells and leaving us susceptible to infections, immune disorders and cancers.
Dec 22, 2017
0
43
Melbourne researchers have solved a longstanding mystery about why some people develop recurring, itchy hives without an apparent allergic trigger, a condition known as chronic spontaneous urticaria (CSU).
Jul 3, 2017
0
110
New funding is enabling Walter and Eliza Hall Institute researchers to develop new approaches to potentially help people with Prader-Willi syndrome, a devastating and incurable genetic condition.
May 20, 2019
0
1508
Researchers have solved a decade-long mystery about a critical protein linked to Parkinson's disease that could help to fast-track treatments for the incurable disease.
Dec 23, 2021
0
110
The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer—the most common form of breast cancer in Australia—according to preclinical studies led by Walter ...
May 7, 2020
0
260
WEHI researchers have made a crucial discovery about how asymptomatic malaria infections impact the body, informing potential strategies to control transmission and improve treatment outcomes.
May 4, 2022
1
38
A coeliac disease vaccine that aims to protect patients from the harmful effects of gluten has entered Phase 2 clinical trials in Melbourne.
Oct 31, 2018
0
84
A team of Institute researchers have discovered how to stop and reverse the growth of lung cancer with a potent combination of three molecules.
Aug 1, 2018
0
151
WEHI researchers have identified an enzyme in the thymus that is essential for immune T cells to correctly identify threats, safeguarding them from going rogue and attacking healthy tissue in the body.
Jan 31, 2022
0
70
